MedTrace Logo

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

NCT06507202 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2024-07-18

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of remimazolam and propofol on postoperative recovery time, complications, and safety in patients undergoing ambulatory upper airway surgery under general anesthesia.

Conditions

  • Laryngeal Disease
  • Pharyngeal Diseases
  • Oral Cavity Disease
  • Nasal Disease

Interventions

DRUG

Remimazolam

General anesthesia is induced and maintained by continuous infusion of remimazolam and remifentanil, and recovered with flumazenil.

DRUG

Propofol

General anesthesia is induced and maintained by continuous infusion of propofol and remifentanil.

Sponsors & Collaborators

  • Chung-Ang University Gwangmyeong Hospital

    lead OTHER

Principal Investigators

  • Se-Hee Min · Chung-Ang University Gwangmyeong Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2025-01-22
Completion
2025-03-22

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06507202 on ClinicalTrials.gov